Clinical Trial Update: Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 multicenter trial evaluating CRx-102 versus its individual components for active rheumatoid arthritis has completed and posted results in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CRx-102

Snippet

Sponsor: Zalicus | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2014-04-29